THE USE OF VITAMIN D ANALOGUES IN COMBINATION WITH IMATINIB IN THERAPY OF NON-SMALL CELL LUNG CANCER

Use of vitamin D analogues selected from tacalcitol and (lS,3R,5E,7E,22E,24S)-24-cyclopropyl-9,10-secochola-5, 7,10(19),22-tetraen-1,3,24-triol (5,6-trans-calcipotriol) in combination with tyrosine kinase inhibitor imatinib in treatment of non-small cell lung cancer. L'invention concerne l'...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KUTNER, ANDRZEJ, WIETRZYK, JOANNA, CHODYNSKI, MICHAL, FILIP-PSURSKA, BEATA, SZELEJEWSKI, WIESLAW
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Use of vitamin D analogues selected from tacalcitol and (lS,3R,5E,7E,22E,24S)-24-cyclopropyl-9,10-secochola-5, 7,10(19),22-tetraen-1,3,24-triol (5,6-trans-calcipotriol) in combination with tyrosine kinase inhibitor imatinib in treatment of non-small cell lung cancer. L'invention concerne l'utilisation d'analogues de vitamine D, choisis parmi le tacalcitol et le (1S,3R,5E,7E,22E,24S)-24-cyclopropyl-9,10-sécochola-5, 7,10(19),22-tétraèn-1,3,24-triol (5,6-trans-calcipotriol), combinés à un inhibiteur de tyrosine kinase, l'imatinib, dans le traitement du cancer du poumon non à petites cellules.